Mentions
Extended reach
Total likes
Video views
AI synopsis
The collection reflects a mostly skeptical tone towards the efficacy of statins, with phrases like 'minuscule benefits' and 'total bullshit,' indicating frustration and disbelief fueled by references to recent systematic reviews and meta-analyses. Conversely, some posts acknowledge the studies but question their clinical relevance, illustrating a debate rooted in the technical details of absolute and relative risk, as well as the influence of pharmaceutical interests.
The discussions contain mixed opinions, with some posts asserting modest benefits of statins and others criticizing their effectiveness and safety, leading to an overall neutral stance.
Many posts reference specific studies, statistics, and technical concepts like absolute vs. relative risk reductions, indicating a moderate level of interest, but some dismissive comments reduce overall engagement.
The discussions show participants analyzing data, debating methodologies, and quoting studies, suggesting active but not deeply immersive engagement.
While some posts highlight the minimal benefits and potential harms of statins, the overall impact appears limited as many discussions are rebuttals or critiques rather than calls for widespread change.
Statins do work, although not as well as most doctors believe they do & not for the reasons that most assume (LDL lowering). They also have more side effects than most people recognize. This must be communicated to patients. https://t.co/7ubE88aLco https://t.co/xxkP1p5r83
Statins have an effect, although not as great as most doctors believe it is. Statins have an effect, although not as great as most doctors believe it is. Statins have an effect, although not as great as most doctors believe it is. https://t.co/7ubE88aLco https://t.co/DgU0EHKRtN
@MEATritionCom kind of takes the wind out of the statin sails when you see the raw (AR) data JAMA Intern Med. doi:10.1001/jamainternmed.2022.0134 https://t.co/2eTuqAWUVl
Si no ha tenido problemas isquémicos ¡NO se mida el colesterol! Venden 1 billón (1 millón de millones) de dólares por año en estatinas, sin añadir salud, disminuyéndola. Ask your doctor to explain your absolute risk reduction. https://t.co/xlX6neAcoz https://t.co/bnjYligxlh
Mínimo beneficio de las estatinas sobre infartos, ictus y muerte en adultos sanos (https://t.co/fvoJyvf7Fc). Su uso puede causar diabetes (https://t.co/W35ZkPVAhK). ¿Te preocupa el colesterol? Mejora tu estilo de vida (https://t.co/ye4NIX1hvO).
MR studies & clinical trials shows trend towards ↓ risk for ACM https://t.co/e1lWGTVzvo https://t.co/r4vygPQYye https://t.co/rZfq2oagB6 https://t.co/c5HpTxMYgm https://t.co/V2TeMqOwlx https://t.co/aV1mARbyv9 https://t.co/dFL8ZSAgw6 https://t.co/eHDHHDUJgw https://t.co/DrtIuHs99s https://t.co/W0CpT9fDgG
In this episode, the surgeons discuss findings from a systematic review of statin use. The study indicates that LDL cholesterol reduction from statins is associated with modest health benefits, including decreased…
This video analyzes the impact of statin treatment on LDL cholesterol reduction and its association with health outcomes like mortality and heart attacks. Recent findings reveal that statin use can significantly improve…
Yes, the RCTs show there is a benefit on all cause death, but it is small in the short term. Definitely no signal for increased death with statin use when limiting to RCTs which are less confounded than the observational data: https://t.co/YVkutJNzD4 https://t.co/U2LMB5J21V
RT @robertlufkinmd: Statins do work, although not as well as most doctors believe they do & not for the reasons that most assume (LDL l…
RT @robertlufkinmd: Statins do work, although not as well as most doctors believe they do & not for the reasons that most assume (LDL l…
RT @robertlufkinmd: Statins do work, although not as well as most doctors believe they do & not for the reasons that most assume (LDL l…
RT @robertlufkinmd: Statins do work, although not as well as most doctors believe they do & not for the reasons that most assume (LDL l…
RT @robertlufkinmd: Statins do work, although not as well as most doctors believe they do & not for the reasons that most assume (LDL l…
RT @robertlufkinmd: Statins do work, although not as well as most doctors believe they do & not for the reasons that most assume (LDL l…
RT @robertlufkinmd: Statins do work, although not as well as most doctors believe they do & not for the reasons that most assume (LDL l…
RT @robertlufkinmd: Statins do work, although not as well as most doctors believe they do & not for the reasons that most assume (LDL l…
RT @robertlufkinmd: Statins do work, although not as well as most doctors believe they do & not for the reasons that most assume (LDL l…
RT @robertlufkinmd: Statins do work, although not as well as most doctors believe they do & not for the reasons that most assume (LDL l…
RT @robertlufkinmd: Statins do work, although not as well as most doctors believe they do & not for the reasons that most assume (LDL l…
RT @robertlufkinmd: Statins do work, although not as well as most doctors believe they do & not for the reasons that most assume (LDL l…
RT @robertlufkinmd: Statins do work, although not as well as most doctors believe they do & not for the reasons that most assume (LDL l…
RT @robertlufkinmd: Statins do work, although not as well as most doctors believe they do & not for the reasons that most assume (LDL l…
RT @robertlufkinmd: Statins do work, although not as well as most doctors believe they do & not for the reasons that most assume (LDL l…
RT @robertlufkinmd: Statins do work, although not as well as most doctors believe they do & not for the reasons that most assume (LDL l…
RT @robertlufkinmd: Statins do work, although not as well as most doctors believe they do & not for the reasons that most assume (LDL l…
RT @robertlufkinmd: Statins do work, although not as well as most doctors believe they do & not for the reasons that most assume (LDL l…
RT @robertlufkinmd: Statins do work, although not as well as most doctors believe they do & not for the reasons that most assume (LDL l…
RT @robertlufkinmd: Statins do work, although not as well as most doctors believe they do & not for the reasons that most assume (LDL l…
RT @robertlufkinmd: Statins do work, although not as well as most doctors believe they do & not for the reasons that most assume (LDL l…
RT @robertlufkinmd: Statins do work, although not as well as most doctors believe they do & not for the reasons that most assume (LDL l…
Statins do work, although not as well as most doctors believe they do & not for the reasons that most assume (LDL lowering). They also have more side effects than most people recognize. This must be communicated to patients. https://t.co/7ubE88aLco https://t.co/xxkP1p5r83
@ValerieAnne1970 A metastudy of 142,000 patients supporting this view: https://t.co/IrieMGoOAU Statin's ability to reduce incidents of death, heart attack or stroke is wildly overrated. https://t.co/Bjma06kKhF
@realDaveFeldman @hubermanlab @PeterAttiaMD MR studies & clinical trials shows trend towards ↓ risk for ACM https://t.co/e1lWGTVzvo https://t.co/r4vygPQYye https://t.co/rZfq2oagB6 https://t.co/c5HpTxMYgm https://t.co/V2TeMqOwlx https://t.co/aV1mARbyv9 https://t.co/dFL8ZSAgw6 https://t.co/eHDHHDUJgw https://t.co/DrtIuHs99s https://t.co/FxSDWnFKbg
@RadovanMaly @hauer_tomas a pa jsou tu novejsi. sice zo neni CT ale... https://t.co/I4j88E9lFJ
@hauer_tomas Od zavedeni statinu v US nárůst CVD o 15%. Kdyby fungovali, tak je to opačně. 60% je přestane do roka brát neb NU. jejich přínos je žádný viz. třeba zde. snizuji LDL, které se ukazuje, ze není zasadni marker. https://t.co/I4j88E9lFJ
RT @AlexTISYoung: @gushamilton Statins offer a relative risk reduction of around 30% for myocardial infarction (Evaluating the Association…
@gushamilton Statins offer a relative risk reduction of around 30% for myocardial infarction (Evaluating the Association Between Low-Density Lipoprotein Cholesterol Reduction and Relative and Absolute Effects of Statin Treatment: A Systematic Review and Meta-analysis | Cardiology | JAMA
RT @ProfTimNoakes: @AustinBaraki @AlexJLeaf Absolute or relative risk? Or does it not matter? https://t.co/Hcxl0iY5WM You might want also t…
@AustinBaraki @AlexJLeaf Absolute or relative risk? Or does it not matter? https://t.co/Hcxl0iY5WM You might want also to check @MaryanneDemasi's article https://t.co/QNWnBRTHD4 Those authors conclude: "Meaning: The study results suggest that the absolute benefits of statins are modest, may not be
@Milosval1 @Simmar_cz Což samozřejmě nijak neoponuje Martinovu postu, myslím, že měl na mysli zásadnější léky než zrovna statiny, u kterých ten přínos není až tak velký, jak se vyzdvihováním relativního snížení mortality namísto absolutního prezentovalo. https://t.co/IlKXoSjDRi
@BitPaine Absolute risk reduction vs relative risk reduction. Not an MD but also didn't fall for Covid jab. These guys refer to 3 lengthy studies. NHA
RT @porterguy1: One of my favorite articles on Absolute (vs Relative) risk reduction regarding statins. People will argue why one is better…
RT @porterguy1: One of my favorite articles on Absolute (vs Relative) risk reduction regarding statins. People will argue why one is better…
RT @porterguy1: One of my favorite articles on Absolute (vs Relative) risk reduction regarding statins. People will argue why one is better…
RT @porterguy1: One of my favorite articles on Absolute (vs Relative) risk reduction regarding statins. People will argue why one is better…
RT @porterguy1: One of my favorite articles on Absolute (vs Relative) risk reduction regarding statins. People will argue why one is better…
One of my favorite articles on Absolute (vs Relative) risk reduction regarding statins. People will argue why one is better than the other, but to me, Absolute is much more “realistic”. As such, statins are NOT what we’ve been sold……. https://t.co/Q4m5iXY4eW
@TomaszLaszcz @KPujdak @OrdoMedicus @DrAseemMalhotra Ravnskov to publikujący lekarz-klinicysta, jego książka opiera się o EBM i publ. naukowe. Wytyczne to syntetyczne opinie - mogą być zbiasowane cherry pickingiem czy konfliktami interesów - niska wiarygodność w EBM. Paper https://t.co/11cNhioAcH ma najwyższą wiarygodność w EBM. https://t.co/EapsQdyL40
@KPujdak @OrdoMedicus @DrAseemMalhotra To też kwestia identyf. grupy docel. dla ew. dyskusji - ja mogę być gdzieś na marginesie.
This is the meta-analysis I was referring to: https://t.co/uk226IEyZz
@cremieuxrecueil Statins have only shown modest reductions in CV outcome in many studies, and even meta analyses: https://t.co/uqsqOM4QDG
RT @robertlufkinmd: Statins have an effect, although not as great as most doctors believe it is. Statins have an effect, although not as g…
RT @robertlufkinmd: Statins have an effect, although not as great as most doctors believe it is. Statins have an effect, although not as g…
Statins have an effect, although not as great as most doctors believe it is. Statins have an effect, although not as great as most doctors believe it is. Statins have an effect, although not as great as most doctors believe it is. https://t.co/7ubE88aLco https://t.co/DgU0EHKRtN
@Topiramatee 1/n Réaction pas sur les pb de cette levure, ok, mais sur le bénéfice/risques des statines. Ces bénéfices paraissent forts uniquement en réduction de risque relatifs. En absolu, seul chiffre parlant, effet non significatif, nombreux essais à l'appui : https://t.co/4BfXAvXTkv
RT @JuanGrvas: Si no ha tenido problemas isquémicos ¡NO se mida el colesterol! Venden 1 billón (1 millón de millones) de dólares por año en…
RT @JuanGrvas: Si no ha tenido problemas isquémicos ¡NO se mida el colesterol! Venden 1 billón (1 millón de millones) de dólares por año en…
RT @JuanGrvas: Si no ha tenido problemas isquémicos ¡NO se mida el colesterol! Venden 1 billón (1 millón de millones) de dólares por año en…
RT @JuanGrvas: Si no ha tenido problemas isquémicos ¡NO se mida el colesterol! Venden 1 billón (1 millón de millones) de dólares por año en…
RT @JuanGrvas: Si no ha tenido problemas isquémicos ¡NO se mida el colesterol! Venden 1 billón (1 millón de millones) de dólares por año en…
RT @JuanGrvas: Si no ha tenido problemas isquémicos ¡NO se mida el colesterol! Venden 1 billón (1 millón de millones) de dólares por año en…
RT @JuanGrvas: Si no ha tenido problemas isquémicos ¡NO se mida el colesterol! Venden 1 billón (1 millón de millones) de dólares por año en…
RT @JuanGrvas: Si no ha tenido problemas isquémicos ¡NO se mida el colesterol! Venden 1 billón (1 millón de millones) de dólares por año en…
RT @JuanGrvas: Si no ha tenido problemas isquémicos ¡NO se mida el colesterol! Venden 1 billón (1 millón de millones) de dólares por año en…
RT @JuanGrvas: Si no ha tenido problemas isquémicos ¡NO se mida el colesterol! Venden 1 billón (1 millón de millones) de dólares por año en…
RT @JuanGrvas: Si no ha tenido problemas isquémicos ¡NO se mida el colesterol! Venden 1 billón (1 millón de millones) de dólares por año en…
RT @JuanGrvas: Si no ha tenido problemas isquémicos ¡NO se mida el colesterol! Venden 1 billón (1 millón de millones) de dólares por año en…
RT @JuanGrvas: Si no ha tenido problemas isquémicos ¡NO se mida el colesterol! Venden 1 billón (1 millón de millones) de dólares por año en…
RT @JuanGrvas: Si no ha tenido problemas isquémicos ¡NO se mida el colesterol! Venden 1 billón (1 millón de millones) de dólares por año en…
RT @JuanGrvas: Si no ha tenido problemas isquémicos ¡NO se mida el colesterol! Venden 1 billón (1 millón de millones) de dólares por año en…
RT @JuanGrvas: Si no ha tenido problemas isquémicos ¡NO se mida el colesterol! Venden 1 billón (1 millón de millones) de dólares por año en…
RT @JuanGrvas: Si no ha tenido problemas isquémicos ¡NO se mida el colesterol! Venden 1 billón (1 millón de millones) de dólares por año en…
RT @JuanGrvas: Si no ha tenido problemas isquémicos ¡NO se mida el colesterol! Venden 1 billón (1 millón de millones) de dólares por año en…
RT @JuanGrvas: Si no ha tenido problemas isquémicos ¡NO se mida el colesterol! Venden 1 billón (1 millón de millones) de dólares por año en…
RT @JuanGrvas: Si no ha tenido problemas isquémicos ¡NO se mida el colesterol! Venden 1 billón (1 millón de millones) de dólares por año en…
RT @JuanGrvas: Si no ha tenido problemas isquémicos ¡NO se mida el colesterol! Venden 1 billón (1 millón de millones) de dólares por año en…
Si no ha tenido problemas isquémicos ¡NO se mida el colesterol! Venden 1 billón (1 millón de millones) de dólares por año en estatinas, sin añadir salud, disminuyéndola. Ask your doctor to explain your absolute risk reduction. https://t.co/xlX6neAcoz https://t.co/bnjYligxlh
@1I1I1I1l1 @JAMAInternalMed https://t.co/ZnBnGKGb2S
@PiotrWitczak_ Statyny "na cholesterol" - skuteczność bliska zeru - publikacja najwyższej wiarygodności wg Medycyny Opartej na Dowodach, z twardymi punktami końcowymi i wyliczonym ARR. Za takie prawdy, promujące naukę i aktualną wiedzę medyczną, też będą ścigać? https://t.co/11cNhioAcH https://t.co/LNEFXXA0yn
Het fabeltje van slechte LDL cholestrol en de zogenaamde statines die hartproblemen voorkomen.. https://t.co/iLrBTSnRar
@DrOzanUnlu Bakalım buradaki çalışma statinlerin sözde olağanüstü faydalarının olmadığını ortaya nasıl da koymuş:https://t.co/iBzM64UG9x
@TGatliff @PierreKory @MidwesternDoc Sure it is easy to proclaim that, so the highest quality evidence according to EBM criteria matter, like syst. revs of RCTs, with hard endpoints and calculated ARR, e.g., this one for statins - minimal benefits: https://t.co/11cNhioAcH Author's comment: https://t.co/3VHwI99D9N https://t.co/jYe6knNnec
@ScottAdamsSays I usually look for highest quality evidence according to EBM hierarchy (like systematic review of RCTs) with hard endpoints and calculated ARR - here quasi zero for statins: https://t.co/11cNhioAcH https://t.co/DjzmXJxgaB
@Dietetykazpasji @PBasiukiewicz @FDietoterapia Może część odpowiedzi może znajdziesz w tym przeglądzie systematycznym i metaanalizie? https://t.co/HSL16NQNPJ
@Marta44407577 @PBasiukiewicz Jeden z niewielu paperów najwyższej wiarygodności w EBM (przegląd syst. i metaanaliza badań randomizowanych), w którym wyliczyli ARR, które okazało się być bliskie zeru. Na YT lekarze z USA nagrywają o tym filmiki, np.: https://t.co/uLm2UHG9RC
@PBasiukiewicz środowisko "naturapeutów" dosyć często mija się z nauką i zdrowym rozsądkiem. Jednak co Pan sądzi o tym artykule https://t.co/BslnVfEBBn
https://t.co/TXAoVJgfLq
RT @GiagkT: Αφού κατέβασαν τα όρια έτσι που να πουλάνε στατίνες σε όποιον αναπνέει… οι μετά- αναλύσεις δεν βλέπουν όφελος : Ο https://t.c…
Αφού κατέβασαν τα όρια έτσι που να πουλάνε στατίνες σε όποιον αναπνέει… οι μετά- αναλύσεις δεν βλέπουν όφελος : Ο https://t.co/8aZKNmbh8S
RT @InPartibusInfid: @PBasiukiewicz @jakubwiech @RuchNarodowy A zalecenia nie są opiniami - interpretacjami? Np. syst. rev. z JAMA dot. sta…
Dit is een van de laatste studies, waar gekeken is naar 21 studies over statines Zelfde onderzoek, alleen 2 verschillende publicaties/links. 'de absolute risicoreductie op overlijden, hartaanval of beroerte was respectievelijk 0,8%, 1,3% en 0,4%' https://t.co/Vw712X6rBe
@Finumus1 There are risks from every Pharmaceutical product No one will tell you that anything is "safe" https://t.co/jHK5i4Isyq
@PBasiukiewicz @jakubwiech @RuchNarodowy A zalecenia nie są opiniami - interpretacjami? Np. syst. rev. z JAMA dot. statynoterapii z twardymi p.k. Jedni powiedzą: stosować s., bo RRR jest do 30% a ARR jest nieistotne. Inni: nie stosować, bo ARR jest przyzerowe a RRR tylko amplifikuje słaby efekt. https://t.co/11cNhioAcH
@MarKes1900 @BkassaNamoomba @StassenFrank @SteviesQuotes https://t.co/x08vxZv5cu
@Paologua7 @cris_cersei https://t.co/m36XRxXYAR
@MutazioneMalata @cris_cersei https://t.co/m36XRxXYAR
Even the conclusion from the individual tags in his tweet (who does not care for statins) found detectable absolute decreases in MACE and ACM over an average 4.5 year trial length for statins
RT @wyadvd: Evaluating the Association Between Low-Density Lipoprotein Cholesterol Reduction and Relative and Absolute Effects of Statin Tr…
Evaluating the Association Between Low-Density Lipoprotein Cholesterol Reduction and Relative and Absolute Effects of Statin Treatment: A Systematic Review and Meta-analysis | Cardiology | JAMA Internal Medicine | JAMA Network https://t.co/eWDYCrpZ66
@MartinKulldorff Exactly. Another great example of a class of drugs that were approved solely on changes in a biomarker, are statins, which in clinical reality do not offer a lot of benefit… https://t.co/JI5bjovA3o
@Joanna_Czarna @Mariusz53300825 @Michal_Doron_45 @TomaszCK1 @KotSzary Ciekawe, czy sami oni i ich rodziny je przyjmują mimo "wskazań". To jak ze szczepieniami p/grypie - 90% medyków nie szczepi się, mimo, że zachęca pacjentów. Ze statyn lekarze śmieją się na całym świecie - tu przykład z USA - omawiają słynny paper z JAMA. https://t.co/uLm2UHGHHa
@MEATritionCom @radfugee @drpablocorral Statin effects All cause mortality : 0.8 % ARR, 9 % RRR MI: 1.3 % ARR, 29 % RRR Stroke: 0.4 %, 14 % RRR Byrne et al., JAMA Int Med, 2022 Evaluating the Association Between Low-Density Lipoprotein Cholesterol Reduction and Relative and Absolute Effects of Statin Treatment
RT @ChristofferBN: MR studies & clinical trials shows trend towards ↓ risk for ACM https://t.co/e1lWGTVzvo https://t.co/r4vygPQYye https://…
RT @ChristofferBN: MR studies & clinical trials shows trend towards ↓ risk for ACM https://t.co/e1lWGTVzvo https://t.co/r4vygPQYye https://…
RT @ChristofferBN: MR studies & clinical trials shows trend towards ↓ risk for ACM https://t.co/e1lWGTVzvo https://t.co/r4vygPQYye https://…
RT @ChristofferBN: MR studies & clinical trials shows trend towards ↓ risk for ACM https://t.co/e1lWGTVzvo https://t.co/r4vygPQYye https://…
RT @ChristofferBN: MR studies & clinical trials shows trend towards ↓ risk for ACM https://t.co/e1lWGTVzvo https://t.co/r4vygPQYye https://…
RT @ChristofferBN: MR studies & clinical trials shows trend towards ↓ risk for ACM https://t.co/e1lWGTVzvo https://t.co/r4vygPQYye https://…
RT @ChristofferBN: MR studies & clinical trials shows trend towards ↓ risk for ACM https://t.co/e1lWGTVzvo https://t.co/r4vygPQYye https://…
MR studies & clinical trials shows trend towards ↓ risk for ACM https://t.co/e1lWGTVzvo https://t.co/r4vygPQYye https://t.co/rZfq2oagB6 https://t.co/c5HpTxMYgm https://t.co/V2TeMqOwlx https://t.co/aV1mARbyv9 https://t.co/dFL8ZSAgw6 https://t.co/eHDHHDUJgw https://t.co/DrtIuHs99s https://t.co/W0CpT9fDgG
@MichaelAlbertMD Not really Statins: All cause mortality : 0.8% ARR, 9% RRR MI: 1.3% ARR, 29% RRR Stroke: 0.4% ARR, 14% RRR Byrne et al., JAMA Int Med, 2022 Evaluating the Association Between Low-Density Lipoprotein Cholesterol Reduction and Relative and Absolute Effects of Statin Treatment
@maherlm @myStankFace @dww3n @DianneCallaha16 @Scaramucci Now you're raising a very good question! Watch this.....https://t.co/82YFA634pM
RT @bava23: Evaluating the Association Between Low-Density Lipoprotein Cholesterol Reduction and Relative and Absolute Effects of Statin Tr…
Evaluating the Association Between Low-Density Lipoprotein Cholesterol Reduction and Relative and Absolute Effects of Statin Treatment: A Systematic Review and Meta-analysis | Cardiology | JAMA Internal Medicine | JAMA Network https://t.co/61qj8k8Fre
@BraciaRodzen Czytałem książkę Panów - lekarz polecił ją osobie z rodziny - cieszę się, że coraz więcej lekarzy pisze o takich rzeczach, bez obawy o możliwą środowiskową dintojrę za psucie interesów rozmaitym koteriom. W USA też o tym mówią (metaanaliza Demasi et al.): https://t.co/GmfWCnfXko
@lipo_fan @AldonSnow48246 @drpablocorral Clinically, lowering LDL-C does not protect against heart disease or death. The absolute risk reduction against myocardial infarction is only 1.3%, and 0.8% against all cause mortality…. https://t.co/JI5bjovA3o
RT @LDLSkeptic: @MEATritionCom kind of takes the wind out of the statin sails when you see the raw (AR) data JAMA Intern Med. doi:10.1001/j…
@DrFisioloco @drpablocorral JAMA Intern Med. 2022;182(5):474-481. doi:10.1001/jamainternmed.2022.0134
@robertlufkinmd Here doctors talk about this paper on YT: https://t.co/rQzB0edzJf https://t.co/GmfWCnfXko The key here IMO is distinction between ARR and RRR.
RT @LDLSkeptic: @MEATritionCom kind of takes the wind out of the statin sails when you see the raw (AR) data JAMA Intern Med. doi:10.1001/j…
RT @LDLSkeptic: @MEATritionCom kind of takes the wind out of the statin sails when you see the raw (AR) data JAMA Intern Med. doi:10.1001/j…
RT @LDLSkeptic: @MEATritionCom kind of takes the wind out of the statin sails when you see the raw (AR) data JAMA Intern Med. doi:10.1001/j…
RT @UrosMikolic: Edini graf, ki ga rabiš o učinkovitosti statinov. Če ne poznaš razlike med relativnim in absolutnim tveganjem, je čas, d…
RT @UrosMikolic: Edini graf, ki ga rabiš o učinkovitosti statinov. Če ne poznaš razlike med relativnim in absolutnim tveganjem, je čas, d…
RT @LDLSkeptic: @MEATritionCom kind of takes the wind out of the statin sails when you see the raw (AR) data JAMA Intern Med. doi:10.1001/j…
RT @LDLSkeptic: @MEATritionCom kind of takes the wind out of the statin sails when you see the raw (AR) data JAMA Intern Med. doi:10.1001/j…
RT @LDLSkeptic: @MEATritionCom kind of takes the wind out of the statin sails when you see the raw (AR) data JAMA Intern Med. doi:10.1001/j…
RT @LDLSkeptic: @MEATritionCom kind of takes the wind out of the statin sails when you see the raw (AR) data JAMA Intern Med. doi:10.1001/j…
RT @LDLSkeptic: @MEATritionCom kind of takes the wind out of the statin sails when you see the raw (AR) data JAMA Intern Med. doi:10.1001/j…
RT @LDLSkeptic: @MEATritionCom kind of takes the wind out of the statin sails when you see the raw (AR) data JAMA Intern Med. doi:10.1001/j…
RT @LDLSkeptic: @MEATritionCom kind of takes the wind out of the statin sails when you see the raw (AR) data JAMA Intern Med. doi:10.1001/j…
RT @LDLSkeptic: @MEATritionCom kind of takes the wind out of the statin sails when you see the raw (AR) data JAMA Intern Med. doi:10.1001/j…
RT @LDLSkeptic: @MEATritionCom kind of takes the wind out of the statin sails when you see the raw (AR) data JAMA Intern Med. doi:10.1001/j…
RT @LDLSkeptic: @MEATritionCom kind of takes the wind out of the statin sails when you see the raw (AR) data JAMA Intern Med. doi:10.1001/j…
RT @LDLSkeptic: @MEATritionCom kind of takes the wind out of the statin sails when you see the raw (AR) data JAMA Intern Med. doi:10.1001/j…
RT @LDLSkeptic: @MEATritionCom kind of takes the wind out of the statin sails when you see the raw (AR) data JAMA Intern Med. doi:10.1001/j…
Edini graf, ki ga rabiš o učinkovitosti statinov. Če ne poznaš razlike med relativnim in absolutnim tveganjem, je čas, da začneš brati. doi:10.1001/jamainternmed.2022.0134 https://t.co/KnO1LuQ56s
RT @LDLSkeptic: @MEATritionCom kind of takes the wind out of the statin sails when you see the raw (AR) data JAMA Intern Med. doi:10.1001/j…
@MEATritionCom kind of takes the wind out of the statin sails when you see the raw (AR) data JAMA Intern Med. doi:10.1001/jamainternmed.2022.0134 https://t.co/2eTuqAWUVl
@OrdoMedicus Tu amerykańscy lekarze omawiają ten paper z JAMA. Jak widać oni, w odróżnieniu pewnie od wielu ich polskich kolegów, nie boją się robić takich rzeczy publicznie. https://t.co/rQzB0edzJf https://t.co/GmfWCnfXko
@Harjas_Grewal Lowering LDL via statins reduced all cause mortality. For every 1mmol/dl reduction in LDL-C, you reduced all cause mortality by 10%. https://t.co/YowsQQg8UR
Tu amerykańscy lekarze omawiają ten paper z JAMA. Jak widać oni, w odróżnieniu pewnie od wielu ich polskich kolegów, nie boją się robić takich rzeczy publicznie. https://t.co/rQzB0edzJf https://t.co/GmfWCnfXko
... reductions in the absolute risk of 0.8% for all-cause mortality, 1.3% for myocardial infarction, and 0.4% for stroke ... compared with control,
@docdu16 Dans la logique RRR versus RRA pour les statines : https://t.co/k87w0W9FTM. Dans la logique des essais arrêtés bien avant terme il y eut : https://t.co/vQIfQD4lS9 hélas pour les diabétiques non confirmé par ailleurs.
@LindaGailBekker @DTHF_SA @iasociety A great primer but why is the relative risk reduction for voluntary medical male circumcision & not also the absolute risk reduction presented, given the importance of absolute risk reduction when making informed decisions with individual patients e.g. https://t.co/vjNr8R7N8W
RT @Dogwalker2019: @SeivwrightTrudy @MdBreathe @CDCDirector https://t.co/sJ4IlF9Qcv You doctors need to wake up. Can't even get this stuff…
@catturd2 https://t.co/rYzTo8thyc turns out statins are total bullshit. My doc never told me. Saw it on YouTube.
@DowdEdward https://t.co/rYzTo8thyc check this out. Statins provide less than 1% absolute risk reduction w/ plenty of side effects. Another big Pharma scam.
@MdBreathe @RobertApter1 @drpaulmarik1 @emilymiller https://t.co/ddZKIqdhPs check this out. My genius doc had me on statins for a decade. Turns out they're total bs. Near zero benefit plenty of side effects. Pharma sucks. Sound familiar?
@SeivwrightTrudy @MdBreathe @CDCDirector https://t.co/sJ4IlF9Qcv You doctors need to wake up. Can't even get this stuff correct. You all just do whatever Rockefeller Big Pharma tells you to do. Sheeple!!!!
https://t.co/mCIK394ZHN
RT @JulioBasulto_DN: Mínimo beneficio de las estatinas sobre infartos, ictus y muerte en adultos sanos (https://t.co/fvoJyvf7Fc). Su uso pu…
RT @JulioBasulto_DN: Mínimo beneficio de las estatinas sobre infartos, ictus y muerte en adultos sanos (https://t.co/fvoJyvf7Fc). Su uso pu…
@EstebanDL Esteban, ya tienes análisis de este articulo? https://t.co/F91mXxshsR
RT @JulioBasulto_DN: Mínimo beneficio de las estatinas sobre infartos, ictus y muerte en adultos sanos (https://t.co/fvoJyvf7Fc). Su uso pu…
RT @JulioBasulto_DN: Mínimo beneficio de las estatinas sobre infartos, ictus y muerte en adultos sanos (https://t.co/fvoJyvf7Fc). Su uso pu…
RT @JulioBasulto_DN: Mínimo beneficio de las estatinas sobre infartos, ictus y muerte en adultos sanos (https://t.co/fvoJyvf7Fc). Su uso pu…
RT @JulioBasulto_DN: Mínimo beneficio de las estatinas sobre infartos, ictus y muerte en adultos sanos (https://t.co/fvoJyvf7Fc). Su uso pu…
RT @JulioBasulto_DN: Mínimo beneficio de las estatinas sobre infartos, ictus y muerte en adultos sanos (https://t.co/fvoJyvf7Fc). Su uso pu…
RT @JulioBasulto_DN: Mínimo beneficio de las estatinas sobre infartos, ictus y muerte en adultos sanos (https://t.co/fvoJyvf7Fc). Su uso pu…
RT @JulioBasulto_DN: Mínimo beneficio de las estatinas sobre infartos, ictus y muerte en adultos sanos (https://t.co/fvoJyvf7Fc). Su uso pu…
RT @JulioBasulto_DN: Mínimo beneficio de las estatinas sobre infartos, ictus y muerte en adultos sanos (https://t.co/fvoJyvf7Fc). Su uso pu…
RT @JulioBasulto_DN: Mínimo beneficio de las estatinas sobre infartos, ictus y muerte en adultos sanos (https://t.co/fvoJyvf7Fc). Su uso pu…
RT @JulioBasulto_DN: Mínimo beneficio de las estatinas sobre infartos, ictus y muerte en adultos sanos (https://t.co/fvoJyvf7Fc). Su uso pu…
RT @JulioBasulto_DN: Mínimo beneficio de las estatinas sobre infartos, ictus y muerte en adultos sanos (https://t.co/fvoJyvf7Fc). Su uso pu…
RT @JulioBasulto_DN: Mínimo beneficio de las estatinas sobre infartos, ictus y muerte en adultos sanos (https://t.co/fvoJyvf7Fc). Su uso pu…
Mínimo beneficio de las estatinas sobre infartos, ictus y muerte en adultos sanos (https://t.co/fvoJyvf7Fc). Su uso puede causar diabetes (https://t.co/W35ZkPVAhK). ¿Te preocupa el colesterol? Mejora tu estilo de vida (https://t.co/ye4NIX1hvO).
@MohammedAlo @brownenglisman @DrAseemMalhotra Alo - The real statin effect (ARR) is ~1%, which is clinically insignificant. doi:10.1001/jamainternmed.2022.0134 "our analysis found that when considering the ARR of statins, the benefits are quite modest, & most trial participants who took statins derived no clinical benefit." https://t.co/mPWJyMsnma
@KenV54 I appreciate that you read my paper. Others are not so open minded. @ethanjweiss Re your concern about anti-statin ideologues misleading the public on relative risk/benefits of statins. We covered that here: https://t.co/nH345BCXy3 see also: doi:10.1001/jamainternmed.2022.0134
@MohammedAlo https://t.co/sCHWEjAAcD
RT @CommunistoObama: Evaluating the Association Between Low-Density Lipoprotein Cholesterol Reduction and Relative and Absolute Effects of…
RT @CommunistoObama: Evaluating the Association Between Low-Density Lipoprotein Cholesterol Reduction and Relative and Absolute Effects of…
Evaluating the Association Between Low-Density Lipoprotein Cholesterol Reduction and Relative and Absolute Effects of Statin Treatment: A Systematic Review and Meta-analysis | Cardiology | JAMA Internal Medicine | JAMA Network https://t.co/ldDngolVot
Evaluating the Association Between Low-Density Lipoprotein Cholesterol Reduction and Relative and Absolute Effects of Statins: Systematic Review/ Meta-analysis; no consistent relationship btwn. lowering LDL-C with statins and death, heart attack or stroke. https://t.co/7gdSHxqvoK
RT @MHcsba: JAMA 2023: "Evaluación de la asociación entre la reducción del colesterol de lipoproteínas de baja densidad y los efectos relat…
RT @MHcsba: JAMA 2023: "Evaluación de la asociación entre la reducción del colesterol de lipoproteínas de baja densidad y los efectos relat…
RT @MHcsba: JAMA 2023: "Evaluación de la asociación entre la reducción del colesterol de lipoproteínas de baja densidad y los efectos relat…
RT @MHcsba: JAMA 2023: "Evaluación de la asociación entre la reducción del colesterol de lipoproteínas de baja densidad y los efectos relat…
RT @MHcsba: JAMA 2023: "Evaluación de la asociación entre la reducción del colesterol de lipoproteínas de baja densidad y los efectos relat…
RT @MHcsba: JAMA 2023: "Evaluación de la asociación entre la reducción del colesterol de lipoproteínas de baja densidad y los efectos relat…
RT @MHcsba: JAMA 2023: "Evaluación de la asociación entre la reducción del colesterol de lipoproteínas de baja densidad y los efectos relat…
RT @MHcsba: JAMA 2023: "Evaluación de la asociación entre la reducción del colesterol de lipoproteínas de baja densidad y los efectos relat…
JAMA 2023: "Evaluación de la asociación entre la reducción del colesterol de lipoproteínas de baja densidad y los efectos relativos y absolutos del tratamiento con estatinas" doi:10.1001/jamainternmed.2022.0134 #MedEd #MedTwitter https://t.co/aZTL9ltbUb
Evaluating the Association Between Low-Density Lipoprotein Cholesterol Reduction and Relative and Absolute Effects of Statin Treatment: A Systematic Review and Meta-analysis | Cardiology | JAMA Internal Medicine | JAMA Network https://t.co/bQ1PQ7266t
RT @GwinyaiMasukume: @DrAseemMalhotra "The study results suggest that the absolute benefits of statins are modest...and should be communica…
It's time for another lesson on NNT, RRR & ARR regarding statins as reviewed by 2 orthopedic surgeons: NNT=77, for 4.4. years, to prevent one MI, so absolute risk reduction ARR is <1% use at your own risk (5:30-7:45) ... https://t.co/l7zJESsusP
RT @GwinyaiMasukume: @DrAseemMalhotra "The study results suggest that the absolute benefits of statins are modest...and should be communica…
RT @GwinyaiMasukume: @DrAseemMalhotra "The study results suggest that the absolute benefits of statins are modest...and should be communica…
RT @GwinyaiMasukume: @DrAseemMalhotra "The study results suggest that the absolute benefits of statins are modest...and should be communica…
RT @GwinyaiMasukume: @DrAseemMalhotra "The study results suggest that the absolute benefits of statins are modest...and should be communica…
@DrAseemMalhotra "The study results suggest that the absolute benefits of statins are modest...and should be communicated to patients as part of informed clinical decision-making as well as to inform clinical guidelines and policy." https://t.co/4uulKPOMqz
@holmanm There is robust evidence showing statins reduce not only heart disease but also death from any cause. Statins reduce all-cause mortality by 9%, Heart Attacks by 29%, and strokes by 14% in this meta analysis of 21 randomized controlled trials https://t.co/VY5u91Gprd
@Raul96096294 @josemacatalina tambiéne existe mucha evidencia de lo contrario: 10.1093/eurheartj/ehx144 10.1136/ebmed-2016-110602 10.1016/S0140-6736(01)05553-2 10.1177/0891988707301867 10.1038/s41598-018-38461-y 10.1093/eurheartj/ehac822 10.1001/jamainternmed.2022.0134 10.1016/j.ahj.2008.08.010
RT @HeartSisters: Great news! 34 years of studies on #statins to ⬇️ heart attack/stroke/death risk have reported heart attack (relative) ri…
Great news! 34 years of studies on #statins to ⬇️ heart attack/stroke/death risk have reported heart attack (relative) risk lowered by 30%! Not so great news: 2022 study reports 1.3% lower (absolute) risk. Journal Club docs explain, +link to 2022 study. https://t.co/nyE8zrvkRc https://t.co/YB3RS5UKxD
@AbbyFerrari @jordanbpeterson Basically: claimed benefits massively exaggerated, side-effects were serious, but understated/hidden/denied, industry pressure/profit-seeking led to vast over-prescription. https://t.co/L6VApZtK6y
I just posted "Evaluating the Association Between Low-Density Lipoprotein Cholesterol Reduction and Relative and Absolute Effects of Statin Treatment (Pub: 2022-03-14)" on Reddit https://t.co/bovRNaOVQK
@TheReluctantIn2 https://t.co/trBgOXQs25
@TheNutrivore @stathitriadis @KenDBerryMD Sorry, the blog appears random and not connected. I’ll help here: from the JAMA article it takes 77 people to be treated for 4.5 years to prevent 1 heart attack. It may help to watch video review of this paper by these Canadian MDs. https://t.co/1dsE2mEJ79
Evaluating the Association Between Low-Density Lipoprotein Cholesterol Reduction and Relative and Absolute Effects of Statin TreatmentA Systematic Review and Meta-analysis https://t.co/DLTaEhmqau
@OGMFTrex https://t.co/kdaMJHbtxQ. Absolute risk reduction of .8% all cause, 1.3% MI and .4% stoke. So it help 4 out of 1000 for stroke etc. utterly ignored by doctors and it was in JAMA. Pharma $$ is all that matters
@PGtzsche1 Do u have a copy of this study? I can't afford to pay 250,- kr :( https://t.co/vpUMNuqiKt
@BrianLenzkes @LDLSkeptic Statins All cause mortality: 0.8 % ARR, 9 % RRR MI: 1.3 % ARR, 29 % RRR Stroke: 0.4 %, 14 % RRR Byrne et al., JAMA Int Med, 2022 Evaluating the Association Between Low-Density Lipoprotein Cholesterol Reduction and Relative and Absolute Effects of Statin Treatment
@ethanjweiss @DrPaulMason @KenDBerryMD @DrAseemMalhotra @SBakerMD @BenBikmanPhD A doc doesn't "withhold" a statin. A doc that reads the lit broadly provides a patient w/ info on the small benefits of statins (doi:10.1001/jamainternmed.2022.0134) & their extensive adverse effects (doi: 10.1097/MED.0000000000000764) then the patient decides if benefits > risks https://t.co/RoQm41HUow
RT @LDLSkeptic: @ethanjweiss @SimmonsBart @NutritionalThe3 @CommunistoObama @ClemensZsofia @Drlipid @ProfTimNoakes @nicknorwitz yep, that 1…
RT @LDLSkeptic: @ethanjweiss @SimmonsBart @NutritionalThe3 @CommunistoObama @ClemensZsofia @Drlipid @ProfTimNoakes @nicknorwitz yep, that 1…
RT @LDLSkeptic: @ethanjweiss @SimmonsBart @NutritionalThe3 @CommunistoObama @ClemensZsofia @Drlipid @ProfTimNoakes @nicknorwitz yep, that 1…
RT @LDLSkeptic: @ethanjweiss @SimmonsBart @NutritionalThe3 @CommunistoObama @ClemensZsofia @Drlipid @ProfTimNoakes @nicknorwitz yep, that 1…
RT @LDLSkeptic: @ethanjweiss @SimmonsBart @NutritionalThe3 @CommunistoObama @ClemensZsofia @Drlipid @ProfTimNoakes @nicknorwitz yep, that 1…
RT @LDLSkeptic: @ethanjweiss @SimmonsBart @NutritionalThe3 @CommunistoObama @ClemensZsofia @Drlipid @ProfTimNoakes @nicknorwitz yep, that 1…
RT @LDLSkeptic: @ethanjweiss @SimmonsBart @NutritionalThe3 @CommunistoObama @ClemensZsofia @Drlipid @ProfTimNoakes @nicknorwitz Did you not…
@ethanjweiss @SimmonsBart @NutritionalThe3 @CommunistoObama @ClemensZsofia @Drlipid @ProfTimNoakes @nicknorwitz Did you not look at the Lipitor ad (see the fine print: 3% vs 2%) or the JAMA Intern Med. systematic review? doi:10.1001/jamainternmed.2022.0134 Let's stay focused on addressing the 1% effect https://t.co/1XvBQOnbZu
@ethanjweiss @SimmonsBart @NutritionalThe3 @CommunistoObama @ClemensZsofia @Drlipid @ProfTimNoakes @nicknorwitz yep, that 1% better than placebo benefit has been an extraordinary advance in therapeutics. Imagine if antibiotics had the same 1% effectiveness as statins AMA Intern Med. doi:10.1001/jamainternmed.2022.0134 https://t.co/CekPK3RM4A
Evaluating the Association Between Low-Density Lipoprotein Cholesterol Reduction and Relative and Absolute Effects of Statin Treatment: A Systematic Review and Meta-analysis https://t.co/e2dQJWXOAD
Can this study bring an end to statin overprescribing? Pharma has already made billions… so no worries there
RT @Carcos2: Estatinas-LDL-reducciones absolutas y relativas de riesgo. Representada prevención primaria y secundaria. 21 ECAs. Diferencia…
RT @Carcos2: Estatinas-LDL-reducciones absolutas y relativas de riesgo. Representada prevención primaria y secundaria. 21 ECAs. Diferencia…
Estatinas-LDL-reducciones absolutas y relativas de riesgo. Representada prevención primaria y secundaria. 21 ECAs. Diferencias LDL entre 16.99-67.57 mg/dL. Sgto medio 4,4 año - 0,8% RAR mortalidad. - 1,5% RAR IAM. - 0,4% RAR ACV 21 ECAs. No parece mucho https://t.co/HtcfAQtbjL
RT @LessIsMoreMed: Patient-oriented gains with LDL lowering are small https://t.co/D9bnU7J916 #cardiology #statin #LDL #moreisnotbetter
RT @rafabravo: Evaluating the Association Between Low-Density Lipoprotein Cholesterol Reduction and Relative and Absolute Effects … https:/…
Patient-oriented gains with LDL lowering are small https://t.co/D9bnU7J916 #cardiology #statin #LDL #moreisnotbetter
RT @rafabravo: Evaluating the Association Between Low-Density Lipoprotein Cholesterol Reduction and Relative and Absolute Effects … https:/…
Evaluating the Association Between Low-Density Lipoprotein Cholesterol Reduction and Relative and Absolute Effects … https://t.co/XHQu0VcgR3
RT @LDLSkeptic: Important paper on how minuscule statin benefits have been amplified by relative risk stats: doi:10.1001/jamainternmed.2022…
@drpablocorral @DrNadolsky @drjohnm That is wrong. Here are statin effects All cause mortality: 0.8 % ARR MI: 1.3 % ARR Stroke: 0.4 % ARR Ref: Byrne et al., JAMA Int Med, 2022 Evaluating the Association Between Low-Density Lipoprotein Cholesterol Reduction and Relative and Absolute Effects of Statin Treatment
Evaluating the Association Between Low-Density Lipoprotein Cholesterol Reduction and Relative and Absolute Effects … https://t.co/Yu3xnhiIwC この報告は大変興味深いのですが，一般化可能性は高いようで低いのではないかと考えます
https://t.co/InjULM0tPo No correlation between low LDL and cardiovascular diseases after all…
RT @spkalantri: @docchennai Evaluating the Association Between Low-Density Lipoprotein Cholesterol Reduction and Relative and Absolute Effe…
RT @Ekkekakis: I should probably stay within my lane, but I am tempted today to offer a brief comment on this recent meta-analysis showing…
@cardiomet_CE Evaluating the Association Between Low-Density Lipoprotein Cholesterol Reduction and Relative and Absolute Effects of Statin TreatmentA Systematic Review and Meta-analysis Will this study change the use of statins?
RT @Ekkekakis: I should probably stay within my lane, but I am tempted today to offer a brief comment on this recent meta-analysis showing…
I should probably stay within my lane, but I am tempted today to offer a brief comment on this recent meta-analysis showing minimal absolute risk reduction from statins, only insofar as it has implications for Evidence-Based Medicine. A short thread... https://t.co/lctgG06AZ2
RT @syuichiao89: 相対危険で3割のリスク低下といえど、絶対差でみれば1.3%程度に過ぎない https://t.co/4QXOsEy6aA
相対危険で3割のリスク低下といえど、絶対差でみれば1.3%程度に過ぎない https://t.co/4QXOsEy6aA
RT @spkalantri: @docchennai Evaluating the Association Between Low-Density Lipoprotein Cholesterol Reduction and Relative and Absolute Effe…
@docchennai Evaluating the Association Between Low-Density Lipoprotein Cholesterol Reduction and Relative and Absolute Effects of Statin Treatment. A Systematic Review and Meta-analysis. JAMA Intern Med. 2022;182(5):474-481
To read on JAMA Evaluating the Association Between Low-Density Lipoprotein Cholesterol Reduction and Relative and Absolute Effects of Statin Treatment: A Systematic Review and Meta-analysis | Cardiology | JAMA Internal Medicine | JAMA Network https://t.co/8kIwH40eGz
Evaluating the Association Between Low-Density Lipoprotein Cholesterol Reduction and Relative and Absolute Effects of Statin Treatment: A Systematic Review and Meta-analysis, from @JAMAInternalMed, free to read online during #IM2022 https://t.co/kN8j3bP4ju https://t.co/APtQlwzPcX
@HarvardHealth Doesn't this study say that absolute risk reduction is minuscule due to statins, if so, why are these still recommended https://t.co/3Kba4DTOeS
RT @seitai_ug: 悪玉コレステロールの薬剤コントロールは心血管障害や全死亡率の減少の効果への証拠が薄い https://t.co/oYlbbZcphw ✅スタチンという薬が高コレステロール治療に使われる薬ですが、死亡率減少とは結び付きにくいんですね…悪玉が大本なのか…
RT @seitai_ug: 悪玉コレステロールの薬剤コントロールは心血管障害や全死亡率の減少の効果への証拠が薄い https://t.co/oYlbbZcphw ✅スタチンという薬が高コレステロール治療に使われる薬ですが、死亡率減少とは結び付きにくいんですね…悪玉が大本なのか…
悪玉コレステロールの薬剤コントロールは心血管障害や全死亡率の減少の効果への証拠が薄い https://t.co/oYlbbZcphw ✅スタチンという薬が高コレステロール治療に使われる薬ですが、死亡率減少とは結び付きにくいんですね…悪玉が大本なのか考えさせられるところ。
@CrowdDemon @RajGaneshHDL @DeanCoulson @MsGlynisBarber @DrAseemMalhotra What about this then: "Evaluating the Association Between Low-Density Lipoprotein Cholesterol Reduction and Relative and Absolute Effects of Statin Treatment: A Systematic Review and Meta-analysis | Cardiology | JAMA Internal Medicine | JAMA Network" https://t.co/Q4k0FKnqpA
RT @Eco_Nutrition1: @raphaels7 Recent JAMA article questioning efficacy of statins. https://t.co/u64v9gOcLx
なるほど！ よくわからん(´・ω・`) https://t.co/o1DANmm06a
@raphaels7 Recent JAMA article questioning efficacy of statins. https://t.co/u64v9gOcLx
This is the study that was discussed in the podcast episode: Evaluating the Association Between Low-Density Lipoprotein Cholesterol Reduction and Relative and Absolute Effects of Statin Treatment: A Systematic Review and Meta-analysis https://t.co/E6cB98dh3b
RT @hhask: Evaluating the Association Between Low-Density Lipoprotein Cholesterol Reduction and Relative and Absolute Effects of Statin Tre…
Evaluating the Association Between Low-Density Lipoprotein Cholesterol Reduction and Relative and Absolute Effects of Statin Treatment: A Systematic Review and Meta-analysis | Cardiology | JAMA Internal Medicine | JAMA Network https://t.co/ifUHGzzoqs
RT @LDLSkeptic: Important paper on how minuscule statin benefits have been amplified by relative risk stats: doi:10.1001/jamainternmed.2022…
To pass on from the other day, statins do NOT work for all cause mortality, MIs, or stroke but sure cause a lot of side effects if your doc still insists that you take them and you acquiesce of course ... https://t.co/CwMDXX9ZUf
Evaluating the Association Between Low-Density Lipoprotein Cholesterol Reduction and Relative and Absolute Effects of Statin Treatment: A Systematic Review and Meta-analysis | Cardiology | JAMA Internal Medicine | JAMA Network or Bogus Statins https://t.co/2wbyuQa9g9
Evaluating the Association Between Low-Density Lipoprotein Cholesterol Reduction and Relative and Absolute Effects of Statin Treatment: A Systematic Review and Meta-analysis | Cardiology | JAMA Internal Medicine | JAMA Network https://t.co/Kq6XgYsYt3
RT @pfanderson: Evaluating the Association Between Low-Density Lipoprotein Cholesterol Reduction and Relative and Absolute Effects of Stati…
Evaluating the Association Between Low-Density Lipoprotein Cholesterol Reduction and Relative and Absolute Effects of Statin Treatment: A Systematic Review and Meta-analysis | Cardiology | JAMA Internal Medicine | JAMA Network https://t.co/obl8cze64z
#論文紹介 スタチンのメタアナで、すべての死亡、心筋梗塞、脳卒中の絶対リスクと相対リスクをまとめた論文です。 絶対リスクはさほど減少しないけれど、相対リスクはかなり減少という結論になっています。 https://t.co/4F6pGTEZSL
Not a convincing case for statins: Evaluating the Association Between Low-Density Lipoprotein Cholesterol Reduction and Relative and Absolute Effects of Statin Treatment: A Systematic Review and Meta-analysis | Cardiology | JAMA Internal Medicine https://t.co/vUIgPFHnfT
RT @LDLSkeptic: Important paper on how minuscule statin benefits have been amplified by relative risk stats: doi:10.1001/jamainternmed.2022…
Evaluating the Association Between Low-Density Lipoprotein Cholesterol Reduction and Relative and Absolute Effects of Statin Treatment: A Systematic Review and Meta-analysis | Cardiology | JAMA Internal Medicine | JAMA Network https://t.co/GpN4dZQA7Y
RT @LDLSkeptic: Important paper on how minuscule statin benefits have been amplified by relative risk stats: doi:10.1001/jamainternmed.2022…
RT @DiljanMansoor: Evaluating the Association Between Low-Density Lipoprotein Cholesterol Reduction and Relative and Absolute Effects of St…
Evaluating the Association Between Low-Density Lipoprotein Cholesterol Reduction and Relative and Absolute Effects of Statin Treatment: A Systematic Review and Meta-analysis | Cardiology | JAMA Internal Medicine | JAMA Network,Think twice about statin https://t.co/BuKQsGEzWv
RT @LDLSkeptic: Important paper on how minuscule statin benefits have been amplified by relative risk stats: doi:10.1001/jamainternmed.2022…
Evaluating the Association Between Low-Density Lipoprotein Cholesterol Reduction and Relative and Absolute Effects of Statin Treatment: A Systematic Review and Meta-analysis | Cardiology | JAMA Internal Medicine | JAMA Network ✅✅✅ https://t.co/B3JBFKZLLx
RT @LDLSkeptic: Important paper on how minuscule statin benefits have been amplified by relative risk stats: doi:10.1001/jamainternmed.2022…
RT @LDLSkeptic: Important paper on how minuscule statin benefits have been amplified by relative risk stats: doi:10.1001/jamainternmed.2022…
RT @LDLSkeptic: Important paper on how minuscule statin benefits have been amplified by relative risk stats: doi:10.1001/jamainternmed.2022…
RT @LDLSkeptic: Important paper on how minuscule statin benefits have been amplified by relative risk stats: doi:10.1001/jamainternmed.2022…
RT @LDLSkeptic: Important paper on how minuscule statin benefits have been amplified by relative risk stats: doi:10.1001/jamainternmed.2022…
RT @LDLSkeptic: Important paper on how minuscule statin benefits have been amplified by relative risk stats: doi:10.1001/jamainternmed.2022…
RT @agingdoc1: Evaluating the Association Between Low-Density Lipoprotein Cholesterol Reduction and Relative and Absolute Effects of Statin…
RT @LDLSkeptic: Important paper on how minuscule statin benefits have been amplified by relative risk stats: doi:10.1001/jamainternmed.2022…
RT @LDLSkeptic: Important paper on how minuscule statin benefits have been amplified by relative risk stats: doi:10.1001/jamainternmed.2022…
RT @LDLSkeptic: Important paper on how minuscule statin benefits have been amplified by relative risk stats: doi:10.1001/jamainternmed.2022…
RT @LDLSkeptic: Important paper on how minuscule statin benefits have been amplified by relative risk stats: doi:10.1001/jamainternmed.2022…
RT @LDLSkeptic: Important paper on how minuscule statin benefits have been amplified by relative risk stats: doi:10.1001/jamainternmed.2022…
RT @LDLSkeptic: Important paper on how minuscule statin benefits have been amplified by relative risk stats: doi:10.1001/jamainternmed.2022…
RT @LDLSkeptic: Important paper on how minuscule statin benefits have been amplified by relative risk stats: doi:10.1001/jamainternmed.2022…
RT @LDLSkeptic: Important paper on how minuscule statin benefits have been amplified by relative risk stats: doi:10.1001/jamainternmed.2022…
RT @LDLSkeptic: Important paper on how minuscule statin benefits have been amplified by relative risk stats: doi:10.1001/jamainternmed.2022…
RT @LDLSkeptic: Important paper on how minuscule statin benefits have been amplified by relative risk stats: doi:10.1001/jamainternmed.2022…
RT @LDLSkeptic: Important paper on how minuscule statin benefits have been amplified by relative risk stats: doi:10.1001/jamainternmed.2022…
RT @LDLSkeptic: Important paper on how minuscule statin benefits have been amplified by relative risk stats: doi:10.1001/jamainternmed.2022…
RT @LDLSkeptic: Important paper on how minuscule statin benefits have been amplified by relative risk stats: doi:10.1001/jamainternmed.2022…
RT @LDLSkeptic: Important paper on how minuscule statin benefits have been amplified by relative risk stats: doi:10.1001/jamainternmed.2022…
RT @LDLSkeptic: Important paper on how minuscule statin benefits have been amplified by relative risk stats: doi:10.1001/jamainternmed.2022…
RT @LDLSkeptic: Important paper on how minuscule statin benefits have been amplified by relative risk stats: doi:10.1001/jamainternmed.2022…
RT @LDLSkeptic: Important paper on how minuscule statin benefits have been amplified by relative risk stats: doi:10.1001/jamainternmed.2022…
RT @LDLSkeptic: Important paper on how minuscule statin benefits have been amplified by relative risk stats: doi:10.1001/jamainternmed.2022…
RT @LDLSkeptic: Important paper on how minuscule statin benefits have been amplified by relative risk stats: doi:10.1001/jamainternmed.2022…
RT @LDLSkeptic: Important paper on how minuscule statin benefits have been amplified by relative risk stats: doi:10.1001/jamainternmed.2022…
RT @LDLSkeptic: Important paper on how minuscule statin benefits have been amplified by relative risk stats: doi:10.1001/jamainternmed.2022…
Evaluating the Association Between Low-Density Lipoprotein Cholesterol Reduction and Relative and Absolute Effects of Statin Treatment: A Systematic Review and Meta-analysis | Cardiology | JAMA Internal Medicine | JAMA Network https://t.co/5HEEsPCGYp
RT @LDLSkeptic: Important paper on how minuscule statin benefits have been amplified by relative risk stats: doi:10.1001/jamainternmed.2022…
RT @LDLSkeptic: Important paper on how minuscule statin benefits have been amplified by relative risk stats: doi:10.1001/jamainternmed.2022…
RT @LDLSkeptic: Important paper on how minuscule statin benefits have been amplified by relative risk stats: doi:10.1001/jamainternmed.2022…
RT @LDLSkeptic: Important paper on how minuscule statin benefits have been amplified by relative risk stats: doi:10.1001/jamainternmed.2022…
RT @LDLSkeptic: Important paper on how minuscule statin benefits have been amplified by relative risk stats: doi:10.1001/jamainternmed.2022…
RT @LDLSkeptic: Important paper on how minuscule statin benefits have been amplified by relative risk stats: doi:10.1001/jamainternmed.2022…
RT @LDLSkeptic: Important paper on how minuscule statin benefits have been amplified by relative risk stats: doi:10.1001/jamainternmed.2022…
I just posted "Evaluating the Association Between Low-Density Lipoprotein Cholesterol Reduction and Relative and Absolute Effects of Statin Treatment" on Reddit https://t.co/oBwKCDoMwc
RT @wyadvd: Evaluating the Association Between Low-Density Lipoprotein Cholesterol Reduction and Relative and Absolute Effects of Statin Tr…
Evaluating the Association Between Low-Density Lipoprotein Cholesterol Reduction and Relative and Absolute Effects of Statin Treatment: A Systematic Review and Meta-analysis | Cardiology | JAMA Internal Medicine | JAMA Network https://t.co/eWDYCrpZ66
@EstebanDL Evaluating the Association Between Low-Density Lipoprotein Cholesterol Reduction and Relative and Absolute Effects of Statin Treatment A Systematic Review and Meta-analysis https://t.co/VdKW8LR6Fa
Evaluating the Association Between Low-Density Lipoprotein Cholesterol Reduction and Relative and Absolute Effects of Statin Treatment https://t.co/tMWhoWHLZS
Evaluating the Association Between Low-Density Lipoprotein Cholesterol Reduction and Relative and Absolute Effects of Statin Treatment: A Systematic Review and Meta-analysis | Cardiology | JAMA Internal Medicine | JAMA Network https://t.co/cxGhlPH3pi https://t.co/3NiHelRTEP
New NNT→Evaluating the Association Between Low-Density Lipoprotein Cholesterol Reduction and Relative and Absolute Effects of Statin Treatment: A Systematic Review and Meta-analysis https://t.co/VYr5l8w2ZG
Evaluating the Association Between Low-Density Lipoprotein Cholesterol Reduction and Relative and Absolute Effects of Statin Treatment: A Systematic Review and Meta-analysis | Cardiology | JAMA Internal Medicine | JAMA Network https://t.co/uNJT3VCB99